Kezar Life Sciences Inc (KZR)
0.81
+0.02
(+2.53%)
USD |
NASDAQ |
Apr 26, 14:34
Kezar Life Sciences Shareholders Equity (Quarterly): 187.57M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 187.57M |
| September 30, 2023 | 215.99M |
| June 30, 2023 | 232.28M |
| March 31, 2023 | 252.49M |
| December 31, 2022 | 269.87M |
| September 30, 2022 | 283.19M |
| June 30, 2022 | 297.36M |
| March 31, 2022 | 232.32M |
| December 31, 2021 | 196.88M |
| September 30, 2021 | 119.48M |
| June 30, 2021 | 129.89M |
| March 31, 2021 | 140.64M |
| December 31, 2020 | 140.98M |
| Date | Value |
|---|---|
| September 30, 2020 | 150.32M |
| June 30, 2020 | 158.32M |
| March 31, 2020 | 122.65M |
| December 31, 2019 | 78.05M |
| September 30, 2019 | 86.50M |
| June 30, 2019 | 94.60M |
| March 31, 2019 | 102.14M |
| December 31, 2018 | 108.80M |
| September 30, 2018 | 114.13M |
| June 30, 2018 | 119.34M |
| March 31, 2018 | 47.44M |
| December 31, 2017 | -25.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
78.05M
Minimum
Dec 2019
297.36M
Maximum
Jun 2022
178.39M
Average
158.32M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| Accuray Inc | 47.65M |
| Tonix Pharmaceuticals Holding Corp | 105.52M |
| Acumen Pharmaceuticals Inc | 266.97M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 221.24M |
| Total Liabilities (Quarterly) | 33.66M |